The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Raveen Rathnasinghe, Sonia Jangra, Anastasija Cupic, Carles Martínez-Romero, Lubbertus C.F. Mulder, Thomas Kehrer, Soner Yildiz, Angela Choi, Ignacio Mena, Jana De Vrieze, Sadaf Aslam, Daniel Stadlbauer, David A. Meekins, Chester D. McDowell, Velmurugan Balaraman, Juergen A. Richt, Bruno G. De Geest, Lisa Miorin, PVI study group, Florian Krammer, Viviana Simon, Adolfo García-Sastre, Michael Schotsaert
doi: https://doi.org/10.1101/2021.01.19.21249592
Raveen Rathnasinghe
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
2Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Sonia Jangra
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Anastasija Cupic
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
2Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Carles Martínez-Romero
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Lubbertus C.F. Mulder
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Thomas Kehrer
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
2Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Soner Yildiz
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Angela Choi
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
2Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Ignacio Mena
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Jana De Vrieze
4Department of Pharmaceutics, Ghent University, Ghent, Belgium
Sadaf Aslam
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Daniel Stadlbauer
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
David A. Meekins
5Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA
Chester D. McDowell
5Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA
Velmurugan Balaraman
5Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA
Juergen A. Richt
5Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA
Bruno G. De Geest
4Department of Pharmaceutics, Ghent University, Ghent, Belgium
Lisa Miorin
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Florian Krammer
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
Viviana Simon
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
6Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai New York, NY, USA
Adolfo García-Sastre
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
6Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai New York, NY, USA
7The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Michael Schotsaert
1Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, USA
3Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA
Data Availability
Data is available upon request.
Posted January 20, 2021.
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Raveen Rathnasinghe, Sonia Jangra, Anastasija Cupic, Carles Martínez-Romero, Lubbertus C.F. Mulder, Thomas Kehrer, Soner Yildiz, Angela Choi, Ignacio Mena, Jana De Vrieze, Sadaf Aslam, Daniel Stadlbauer, David A. Meekins, Chester D. McDowell, Velmurugan Balaraman, Juergen A. Richt, Bruno G. De Geest, Lisa Miorin, PVI study group, Florian Krammer, Viviana Simon, Adolfo García-Sastre, Michael Schotsaert
medRxiv 2021.01.19.21249592; doi: https://doi.org/10.1101/2021.01.19.21249592
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Raveen Rathnasinghe, Sonia Jangra, Anastasija Cupic, Carles Martínez-Romero, Lubbertus C.F. Mulder, Thomas Kehrer, Soner Yildiz, Angela Choi, Ignacio Mena, Jana De Vrieze, Sadaf Aslam, Daniel Stadlbauer, David A. Meekins, Chester D. McDowell, Velmurugan Balaraman, Juergen A. Richt, Bruno G. De Geest, Lisa Miorin, PVI study group, Florian Krammer, Viviana Simon, Adolfo García-Sastre, Michael Schotsaert
medRxiv 2021.01.19.21249592; doi: https://doi.org/10.1101/2021.01.19.21249592
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (191)
- Cardiovascular Medicine (2838)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12545)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4419)
- Geriatric Medicine (401)
- Health Economics (713)
- Health Informatics (2846)
- Health Policy (1047)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (221)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6768)
- Radiology and Imaging (1487)
- Respiratory Medicine (898)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (173)